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Background: Circadian theories for major depressive disorder have suggested that the rhythm of the circadian
pacemaker is misaligned. Stable phase relationships between internal rhythms, such as temperature and rest/activity, and
the external day-night cycle, are considered to be crucial for adapting to life in the external environmental. Therefore, the
relationship and possible alterations among (i) light exposure, (ii) activity rhythm, and (iii) temperature rhythm could be
important factors in clinical depression. This study aimed to investigate the rhythmic alterations in depression and
evaluate the ability of chronobiological parameters to discriminate between healthy subjects and depressed patients.
Methods: Thirty female subjects, including healthy subjects, depressed patients in the first episode, and major
recurrent depression patients. Symptoms were assessed using Hamilton Depression Scale, Beck Depression Inventory
and Montgomery-Äsberg Scale. Motor activity, temperature, and light values were determined for 7 days by actigraph,
and circadian rhythms were calculated.
Results: Depressed groups showed a lower amplitude in the circadian rhythm of activity and light exposure, but a
higher amplitude in the rhythm of peripheral temperature. The correlation between temperature and activity values
was different in the day and night among the control and depressed groups. For the same level of activity, depressed
patients had lowest temperature values during the day. The amplitudes of temperature and activity were the highest
discriminant parameters.
Conclusions: These results indicate that the study of rhythms is useful for diagnosis and therapy for depressive mood
disorders.
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Depression is among the most prevalent, debilitating,
and potentially fatal mental disorders [1,2]. The onset of
symptoms is sex-dependent, with the highest prevalence
in females. Experimental evidence suggests that during
development, alterations in the medial amygdala cause* Correspondence: mpaz@cpovo.net
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reproduction in any medium, provided the orsexual dimorphism in the expression level of an evolu-
tionarily conserved pathway that affects mitochondrial
and circadian clock function [3]. Mitochondrial and
circadian clock function are associated with mood
disorders [4].
The brain's primary circadian pacemaker is the supra-
chiasmatic nucleus (SCN), which is synchronized by light
input from melanopsin-containing retinal ganglion cells,
and consecutively its system synchronizes subsidiary oscil-
lators [4,5]. Changes in SCN-dependent rhythms have
been observed in patients with mood disorders [6]. There-
fore, depressive symptoms can be a consequence of anLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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light exposure [7].
Depressive symptoms improve after light therapy [8].
The efficacy of bright light therapy as an adjuvant treat-
ment to antidepressant pharmacotherapy in nonseasonal
depression has also been demonstrated [9]. Studies sug-
gest that bright light therapy alone is more efficacious for
seasonal affective disorder than it is for nonseasonal de-
pression [9], probably because there are different levels of
SCN involvement in the aetiology of depressive mood.
In depressive patients, changes in the time of light ex-
posure and social life show greater variability and are
prone to desynchronization in rest-activity and tem-
perature [10]. One of the first circadian theories for
major depressive disorder suggested that the circadian
pacemaker is misaligned with respect to the timing of
sleep, as well as to the activity-rest rhythm [11,12]. This
evidence combined with the clinical observation that al-
tered physical activity has long been recognized as a fea-
ture of depression [13], indicate that this variable could
be one of the main parameters involved in mood disor-
ders [14].
Other characteristics of patients with depressive episodes
include the presence of daytime mood variations, and al-
terations in the circadian secretion of cortisol and adreno-
corticotropic hormone [6]. Exogenous administration of
human corticotropin-releasing hormone provokes signifi-
cant phase-advancements in body temperature [15], one of
the most robust circadian rhythms [16]. Abnormal body
temperature variation, which has been observed in de-
pressed patients, could be considered as a functional dis-
turbance located at the level of circadian organization [17].
Stable phase relationships between internal rhythms,
such as temperature and rest/activity, and the external
day-night cycle, are considered important for adapting to
life in the external environmental [18,19]. Therefore, the
relationship and possible alterations among (i) light expos-
ure, (ii) activity rhythm, and (iii) temperature rhythm
could be important factors in clinical depression. We hy-
pothesized that these three variables are disrupted in de-
pression and that they might be important for the
evaluation of clinical depression. Therefore, we designed a
cross-sectional study to examine this chronodisruption in
depression, and to evaluate the capacity of chronobiotic
parameters to discriminate between healthy subjects, de-
pressed patients in their first episode without previous
treatment, and patients with major recurrent depression.
Methods
Sample characteristics
The investigation followed a cross-sectional design and
was conducted in the city of Porto Alegre, which is lo-
cated in the extreme south of Brazil (30° 05' South and
51° 10' West). This study was performed according tointernational ethical standards [20] and was conducted
in accordance with the Declaration of Helsinki. The
study protocol (number 06-268 GPPG/HCPA) was ap-
proved by the Ethics Committee at the Hospital de
Clínicas de Porto Alegre (HCPA), and all participants
signed an informed consent form.
The flowchart of the study protocol is shown in
Figure 1. Thirty female patients aged between 18 and 60 -
years (10 controls and 20 depressed patients) were se-
lected using the Self-Report Questionnaire (SRQ-20),
which was used to assess minor psychiatric disorders at
the municipal primary health care units. The volunteers
were referred for an additional assessment by psychia-
trists in the psychiatric outpatient clinic at the hospital
(HCPA). The Structured Clinical Interview for DSM-IV
(SCID) was conducted to diagnose depression.
Ten patients met the criteria for a first depressive epi-
sode; they had not used antidepressants previously (de-
pressive-first episode: Dfe group). Ten patients were
diagnosed with major recurrent depression (mean num-
ber of episodes = 3) and were using antidepressants (de-
pressive-chronic: Dc group).
The subjects in the control group (10 healthy subjects)
were matched by age with those in the depressive
groups. All the exclusion criteria for the depressive
groups were applied to the control group. Moreover, ex-
clusion criteria for the control group also included the
presence of symptoms meeting criteria for diagnosis of a
mood disorder, the presence of greater than mild symp-
toms on any depression scale, and the use of psycho-
pharmacological drugs.
None of the patients had performed shift work or had
transmeridian travel during the month preceding the
study. Exclusion criteria were the use of beta-blockers or
diuretics, the presence of severe psychiatric co-morbidity,
and the following standard exclusion criteria for clinical
trials: pregnancy, chronic clinical disorder, and alcohol or
illicit drug abuse.
To avoid bias in measurements, trained interviewers
assessed depressive symptoms using the following ques-
tionnaires validated in Brazil: the Hamilton Depression
Scale (HAM-D) [21,22], the Beck Depression Inventory
(BDI) [23,24], and the Montgomery-Äsberg Scale
(MADRS) [25]. The participants were blinded to the ob-
jective of the study.
Instruments
Assessment of minor psychiatric disorders
Minor psychiatric disorders were assessed with the SRQ-
20, adapted by Mari and Williams [2]. The presence of
minor psychiatric disorders was defined by an SRQ-20
score ≥7 for women. Using these cut-off values, the sen-
sitivity of the method to detect minor psychiatric disor-
ders is 83.5%, and the specificity is 80% [2].
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Figure 1 Flowchart of the study protocol.
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The HAM-D scale includes 21 questions, with the final
score ranging from 0 to 62 [21]. Patients with HAM-D
scores of 11 to17 were classified as having mild depres-
sion, 18 to 25 as moderate depression, and >25 as having
a severe depressive episode [22].
The BDI is a self-report scale that can be used as a
screening questionnaire to assess the cognitive, affective
[23], and somatic symptoms of depression [24]. The BDI
includes 21 items; each response is assigned a score
ranging from 0 (no symptoms of depression) to 3 (severe
symptoms of depression). The total score ranges from 0
to 63. Total scores from 0 to 9 points indicate no or
minimal depressive symptoms, 10 to 16 points indicate
mild depressive symptoms, 17 to 29 points indicate
moderate depressive symptoms, and 30 to 63 points
indicate severe depressive symptoms, as described previ-
ously [24].
The MADRS scale contains 10 questions that are each
scored from 0 to 6 points. The final score ranges from 0
to 60 points [25] An intra-class correlation coefficient of
0.96 was observed for the agreement between thedifferent evaluators. Individuals with scores <7 were
classified as being without depressive symptoms.
Assessment of temperature, activity, and light rhythms
The rhythm variables were assessed by continuous
actigraphy monitoring with light sensors in all patients
over 7 days. The actigraph model used in this study was
a TempatilumeW (Cebrasil, Inc. Brazil), which measures
activity, peripheral temperature, and ambient light ex-
posure. The Tempatilume is an activity monitor
designed for the long term monitoring of activity in hu-
man subjects. This monitor contains an accelerometer
that is capable of sensing any motion with a minimal re-
sultant force of 0.01 g. All communication with the
actigraph is accomplished using a Tempatilume readerW
(Cebrasil, Inc.) that is connected to a computer via a
USB port. The epoch length was 1 minute. The software
used was Tempatilume Rhythm AnalysisW (Cebrasil,
Inc.). The data were converted into ASCII files that
could be processed by the chronobiology program “El
Temps”. The subjects wore wrist actigraphs with light
sensors for 7 days.
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Motor activity and peripheral temperature data were
first visually inspected by double-plotted graphs. The cir-
cadian rhythm was examined by the periodogram of
Sokolove and Bushell [26], which provides the period of
the most significant rhythm and the percentage of vari-
ance (PV) explained by this rhythm. PV was used as a
marker of the stability and prominence of the rhythm.
Periods and PV were considered significant at a level of
p < 0.05. Moreover, for each patient, data were fitted to a
cosinusoidal curve of a 24-hour rhythm (cosinor ana-
lysis). This analysis provided the amplitude, mesor, and
acrophase of the adjusted rhythm. The mean and stand-
ard errors of the daily acrophases were calculated. The
stability of the daily phases of each individual circadian
rhythm was calculated by the Rayleigh z test. The
resulting vector angle indicated the mean peak time for
each individual rhythm, and the magnitude of the vector
(r) indicated the phase coherence. Therefore, the higher
the r, the more coherent the phase of the rhythm was
for this individual. To study the phase tendencies of each
group, Rayleigh z tests were used in relation to the indi-
vidual vectors, as described above, to obtain the mean
vector of each group.
The mean daily profiles of the rhythm of each variable
and for each patient were calculated. From these pro-
files, we calculated the mean daily values of motor activ-
ity, peripheral temperature, and light, as well as the
diurnal and nocturnal mean values of each of the three
variables. We also calculated the time that the variable
was above the mean.
In addition, to study the relationship between tem-
perature and activity rhythms in each subject, the activity
data were transformed into percentiles for each individual
(10 levels were calculated based on the maximum activity
of each individual), and the temperature values corre-
sponding to each activity level were determined. The rela-
tionships between activity and temperature were plotted
separately for day and night. This methodology has been
described elsewhere [27,28].
Statistical analysis
Data are expressed as the mean ± SEM. The calculated
variables were tested using one-way analysis of varianceTable 1 Differences in demographic characteristics between t
Dfe Dc
Mean ± SE Mean ± SE
Age 44 + 3.94 44.82 + 3.33
Beck 17.90 + 2.8 32.27 + 4.3
Hamilton 17.40 + 4.8 25.18 + 9.27
Montgomery-Asberg 21.5 + 5.08 23.00 + 9.76
Dfe Depressives-first episode, Dc Depressives-chronic, SE Standard error of the mean(ANOVA). We also estimated statistic partial Eta
squared to measure the effect size 0.04 a medium effect
and 0.1 a large effect size, where 0.01 constitutes a small
effect, 0.04 a medium effect and 0.1 a large effect. All
post-hoc comparisons were Bonferroni corrected. The
rhythm variables derived from the cosinor analysis,
amplitude (difference between the mesor and peak), and
acrophase (clock time of the peak value), were also eval-
uated by discriminant analysis to estimate which vari-
able (light, activity, or temperature rhythm) presented
higher coefficients to discriminate patients in the Dc
group from those in the Dfe group, and the control
group from both depressive groups. For all analyses, the
statistical significance was set at p < 0.05, with a two-
tailed hypothesis. When only two means were compared,
data were tested by independent Student’s t-tests. Data
were analysed using SPSS version 16.0 (SPSS, Chicago,
IL, USA).
Results
Demographic characteristics among the depressive pa-
tient groups are shown in Table 1. Although the patients
were taking medication, the Dc group had higher scores
than those in the Dfe group in the BDI and HAM-D, but
not with the MADRS instrument. Also, there was no
significant age difference among groups (F (df ) = 0.17(2);
P > 0.05).
When the mean values for motor activity and tem-
perature for day and night were calculated for the three
groups (Figure 2), motor activity had the highest values
during the day, and peripheral temperature had the
highest values during the night, as expected. For motor
activity and temperature, differences between the groups
were found in diurnal values, but not in nocturnal
values. Diurnal activity was significantly higher in the
control group than in the depressive groups (ANOVA, F
(df ) = 23.63(2); p < 0.001; eta-squared = 0.673). Post-hoc
analysis showed that differences were greater between
control and Dfe (p < 0.0001) than under control and Dc
(p < 0.01), and also that diurnal activiy was higher in Dfe
than in Dc (p < 0.05). With regard to peripheral
temperature, although diurnal values appeared signifi-
cantly higher in the control group than in the depressive
groups, ANOVA did not show statistically significanthe depressive disorder groups



















































Figure 2 Mean levels of motor activity and peripheral temperature during the day (D) and night (N) for each group (Dfe: depressive-
first episode, Dc: depressive-chronic). **p < 0.001; *p < 0.05.
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values of Dfe group; nevertheless, Student’s t test show
differences between control and Dc (Student’s t test, t =
2.346, p < 0.05).
Study of the amplitude of the rhythm, obtained by
cosinor analysis (Figure 3A1, B1, C1), showed that the
amplitude values for activity were significantly higher in
the control group than in either of the depressive groups
(ANOVA, F(df ) = 23.72(2); p < 0.001; eta-squared =















































   













Figure 3 Amplitude values (left) and PV explained by the 24 h rhythm
Standard errors for the activity, peripheral temperature, and light exposure
percentage of the variance) are shown.for activity in the Dfe group compared with those in the
Dc group were close to significance (p = 0.08). The amp-
litude of the temperature rhythm was not different
between the groups. The amplitude of the light intensity
was higher in control than in depressive groups (ANOVA,
F(df ) = 3.729(2); p < 0.05; eta-squared = 0.245). No dif-
ferences were found in light intensity in the depres-
sive groups.
The PV of activity and temperature values explained
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obtained by the Sokolove and Bushell periodogram (right).
of each group (Dfe: depressive-first episode; Dc: depressive-chronic; PV:
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group, temperature tended to be slightly lower than in
the depressive groups (ANOVA, F(df ) = 2.697(2); p =
0.088; eta-squared = 0.183). The PV of light intensity
values was higher in the control group (ANOVA, F(df )
= 6.69(2); p < 0.01; eta-squared = 0.358) than in either of
the depressive groups, indicating more stability and
higher values of this variable in the controls.
To determine if there were differences in acrophase
values of the three variables among the three groups,
comparison of acrophases (expressed in radians) was
conducted by Rayleigh analysis (Figure 4). No differences
were observed in acrophase among the groups for
temperature, activity, or light. As expected, light expos-
ure and activity rhythms had similar acrophase values,
which were opposite to the acrophase value for periph-
eral temperature.
Analysis of the daily profile indicated that the time
when temperature was above the mean was shorter in
the control group than in the depressive groups (mean,
control: 8 h and 15 min ±26 min; Dfe: 9 h and 36 min ±
47 min; Dc: 10 h and 16 min ± 27 min), although signifi-




Figure 4 Rayleigh z tests for activity, peripheral temperature, and ligh
indicates the position of the mean acrophase of each individual in the gro
acrophase, and the fiducial limits are also indicated. The size of the vector
significant level of p = 0.05.and Dc groups (Student’s t-test, p < 0.05). No differences
were found in the time above the mean for light and
activity.
The relationships between temperature and the level
of activity for each individual differed from day to night.
In the day and at night, peripheral temperature de-
creased as activity increased (Figure 5). However, for the
same level of activity, nocturnal temperatures were
higher than those obtained during the day, reflecting the
circadian rhythm. It is worth noting that the healthy
subjects showed less contrast in temperature values be-
tween day and night than did the depressive patients.
There were no differences between the two groups of
depressive patients (Figure 5).
The results of the discriminate analyses are shown in
Table 2. The high discriminant coefficients (> 0.3) were
branched. The control group could be discriminated
from the Dfe group by high coefficients of the ampli-
tudes and acrophases of temperature and activity, with
the amplitude of temperature as the highest discrimin-
ant parameter. The chronic depression group was differ-
entiated from the control and the Dfe groups by the
activity amplitude.ctivity Light
t exposure. Each circle represents 24 hours, and each triangle
up. The black point of the inside vector represents the mean





























































Figure 5 Mean levels of peripheral temperature (diurnal and
nocturnal) expressed as a function of activity level (expressed
as the percentage of the maximum activity for each group).
Table 2 Discriminate analysis of rhythm parameters
(amplitude and acrophase) among the control group and
the depressive groups (Dfe and Dc)
Variable Control vs Dfe Control vs Dc Dfe vs Dc
Amplitude
Temperature 0.820 -0.269 0.240
Activity -0.664 0.912 0.398
Light -0.096 0.178 0.252
Achrophase
Temperature -0.442 0.120 -0.111
Activity 0.373 -0.104 0.174
Light 0.039 -0.047 -0.053
Dfe Depressives-first episode, Dc Depressives-chronic, Amplitude: difference
between mesor and peak; Acrophase: clock time of the peak value.
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In our study, we demonstrated differences in rest-activity,
peripheral temperature, and light intensity rhythms in
depressive patients compared with healthy subjects.
Additionally, we described the capacity of chronobiologi-
cal variables to discriminate among the different stages
(acute and chronic) of a depressive disorder.
With regard to the rest-activity rhythm, we observed
that patients in their first depressive episode showed a
decrease in amplitude compared with the control group.
The amplitude was also reduced in patients with chronic
depression. The differences in amplitude might have
been due to the subjects’ different activity levels because
these differences were reduced according to the severityof the illness [29]. Because this variable was found to be a
high coefficient for discriminating chronic depressive pa-
tients, it could be an important tool in clinical practice to
evaluate the stage and prognosis of major depressive
disorder. The increased circadian amplitude in the rest-
activity rhythm of healthy subjects could also be explained
by the increased entrainment to external Zeitgebers, most
likely by the maintenance of robust social and biological
Zeitgebers that are essential for life [30].
In the current study, we found that the duration of
time that the temperature remained above the mean was
higher in the depressive groups than in the control
group, suggesting that this variable is a good indicator of
the time that subjects might have been in bed or had a
low activity level. Activity level is decreased with the se-
verity of the pathology. Several hypotheses have been
proposed attempting to relate circadian differences with
mood disorders [31], including the phase advance hy-
pothesis, and reduced amplitudes in depressed patients.
Findings from previous studies on the amplitude of the
temperature rhythm in depressed patients have been in-
consistent, perhaps reflecting differences in the samples
of depressed patients studied due to differences in the
stage or aetiology of the disorder. Therefore, an elevated
nocturnal temperature has been reported by some au-
thors [32,33], whereas a blunted or unchanged tempe-
rature rhythm has been observed by others [34].
In our study, the amplitude of the activity rhythm was
capable of discriminating healthy people from acutely
depressed patients. This result might be a marker of the
beginning of the disorder because the coefficient of the
amplitude of activity presented as the highest discrimin-
ant value (0.8). However, the amplitude of peripheral
temperature was insufficient to identify differences
among groups, although the PV of the temperature
rhythm had a tendency to increase with the severity of
the pathology, suggesting a more stable rhythm in per-
ipheral temperature values of depressed patients.
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However, in our study, we observed that there were differ-
ences between day and night for temperature values for
the same relative level of activity. This observation sug-
gests that peripheral temperature followed a real endogen-
ous rhythm independent of activity. Healthy subjects
demonstrated fewer differences between temperature
values during the day and night, which is consistent with
lower amplitude values in this variable. This suggested
that high activity in healthy people might have masked the
temperature rhythm. However, this suggestion is not com-
pletely valid, because for all levels of activity, the differ-
ences between nocturnal and diurnal values were lowest
in the control group (Figure 5).
The peripheral temperature rhythm is partly the result
of alternate balances between parasympathetic (vasodila-
tation) and sympathetic (vasoconstriction) actions in the
peripheral skin vessels, which are driven by the SCN
[35,36]. Therefore, the lower levels of peripheral tem-
perature during the day in depressed patients could be
attributable to higher activity of the sympathetic system.
This relationship supports the idea that, in depres-
sion, there might be an imbalance in the autonomic
system, which could be due to abnormalities in circadian
system regulation [37].
Additionally, the results of intrinsic biological rhythms
must be interpreted by examining the external rhythms
induced by light exposure. The fit of the amplitude of light
was highest in the control, indicating that these subjects
were exposed to higher levels of light intensity. The ampli-
tude and stability of the light rhythms were lower in the
depressive groups than in the control group, which indi-
cated that light may have had less influence on endogen-
ous rhythms in depressed patients than in controls. Our
results demonstrated that although the amplitude of light
intensity was not different among the groups, the PV of
light intensity values was higher in the control group than
in the depressive groups, indicating more stability of this
variable in the control group. Some studies have demon-
strated a relationship between light intensity and seasonal
depression [38,39]. One hypothesis that may help explain
abnormalities in the regulation of circadian rhythms has
suggested that changes in the length of the endogenous
period leads to changes in the phase angle of light syn-
chronisation [40]. Therefore, the intensity and period
when the subject is exposed are important, as well as the
phase and the spectrum.
The simultaneous assessment of light, activity, and
temperature rhythms in the current study was essential
because all three variables provided information on the
functioning of the circadian pacemaker, as well as possible
masking due to light exposure, and its effects on the pace-
maker. Discriminant analysis provided important informa-
tion about the capability of chronobiotic parameters to beconsidered as a tool for the diagnosis and prognosis of de-
pression. The next step in future research is to perform a
prospective study to evaluate the sensitivity, specificity,
and predictive value of these parameters .
One alternative explanation for our findings related to
the changes in chronobiological parameters may be re-
lated to the antidepressant treatment used in the chronic-
ally depressed patients. One study using an agonist at MT
(1)/MT(2) melatonin receptors and an antagonist at 5-HT
(2C) serotonin receptors showed a significant difference in
the relative amplitude of the circadian rest-activity cycle
[41]. Additionally, antidepressant treatments, including
tricyclic medications, increase the circadian amplitude of
temperature [42]. In our study, the effect of medication
could not be clearly considered. Notably, the Dc patients
were chronic patients who had received medication. How-
ever, in spite of their treatment, they scored higher on the
depressive scales than did the Dfe patients. Therefore, we
conclude that, in the current study, alterations in circadian
rhythms were due to severity of the pathology and not ne-
cessarily to the medication itself.
Limitations due to the design of the study are as follows:
(i) this was a cross-sectional study, and therefore, we could
not establish a direct cause-consequence relationship; (ii)
depressive subjects with more intense symptoms were
under treatment; therefore, we could not affirm that the
changes in rhythm were due only to the effect of the se-
verity of the symptoms; and (iii) in this study, we assessed
the intensity but not the quality of the light.
Finally, this study raises some hypotheses to be tested
in longitudinal studies. First, it suggests that in subjects
with diseases, there is a shift in circadian rhythm to
adapt and maintain the energy needed for survival. Sec-
ond, the results in this study underscore the theory that
the lack of synchronisation between rhythms can be
decoded by physiological systems as a stressor. This
chronodisruption is capable of starting, accelerating, per-
petuating, and exacerbating neuropsychiatric symptoms
because the rhythms are integrated into basic cellular
endocrine rhythms that build rhythmic, structural, and
functional networks.
Conclusions
In conclusion, we show that the amplitude and stability
of circadian rhythms are influenced by depressive states.
This result correlates with the severity of the clinical
manifestation of depression may be an important tool to
be used in clinical set.
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